These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 22686473

  • 1. Targeting endoplasmic reticulum signaling pathways in cancer.
    Martinon F.
    Acta Oncol; 2012 Sep; 51(7):822-30. PubMed ID: 22686473
    [Abstract] [Full Text] [Related]

  • 2. Proteasome inhibitor PS-341 induces apoptosis through induction of endoplasmic reticulum stress-reactive oxygen species in head and neck squamous cell carcinoma cells.
    Fribley A, Zeng Q, Wang CY.
    Mol Cell Biol; 2004 Nov; 24(22):9695-704. PubMed ID: 15509775
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Bortezomib inhibits PKR-like endoplasmic reticulum (ER) kinase and induces apoptosis via ER stress in human pancreatic cancer cells.
    Nawrocki ST, Carew JS, Dunner K, Boise LH, Chiao PJ, Huang P, Abbruzzese JL, McConkey DJ.
    Cancer Res; 2005 Dec 15; 65(24):11510-9. PubMed ID: 16357160
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. TNF potentiates anticancer activity of bortezomib (Velcade) through reduced expression of proteasome subunits and dysregulation of unfolded protein response.
    Nowis D, McConnell EJ, Dierlam L, Palamarchuk A, Lass A, Wójcik C.
    Int J Cancer; 2007 Jul 15; 121(2):431-41. PubMed ID: 17373661
    [Abstract] [Full Text] [Related]

  • 9. Proteasome inhibitors induce a terminal unfolded protein response in multiple myeloma cells.
    Obeng EA, Carlson LM, Gutman DM, Harrington WJ, Lee KP, Boise LH.
    Blood; 2006 Jun 15; 107(12):4907-16. PubMed ID: 16507771
    [Abstract] [Full Text] [Related]

  • 10. Nelfinavir and bortezomib inhibit mTOR activity via ATF4-mediated sestrin-2 regulation.
    Brüning A, Rahmeh M, Friese K.
    Mol Oncol; 2013 Dec 15; 7(6):1012-8. PubMed ID: 23916134
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The unfolded protein response as a target for anticancer therapeutics.
    Wang M, Law ME, Castellano RK, Law BK.
    Crit Rev Oncol Hematol; 2018 Jul 15; 127():66-79. PubMed ID: 29891114
    [Abstract] [Full Text] [Related]

  • 13. Lysosomes and endoplasmic reticulum: targets for improved, selective anticancer therapy.
    Linder S, Shoshan MC.
    Drug Resist Updat; 2005 Aug 15; 8(4):199-204. PubMed ID: 16055370
    [Abstract] [Full Text] [Related]

  • 14. Targeting the integrated networks of aggresome formation, proteasome, and autophagy potentiates ER stress‑mediated cell death in multiple myeloma cells.
    Moriya S, Komatsu S, Yamasaki K, Kawai Y, Kokuba H, Hirota A, Che XF, Inazu M, Gotoh A, Hiramoto M, Miyazawa K.
    Int J Oncol; 2015 Feb 15; 46(2):474-86. PubMed ID: 25422130
    [Abstract] [Full Text] [Related]

  • 15. Ritonavir interacts with bortezomib to enhance protein ubiquitination and histone acetylation synergistically in renal cancer cells.
    Sato A, Asano T, Ito K, Asano T.
    Urology; 2012 Apr 15; 79(4):966.e13-21. PubMed ID: 22296623
    [Abstract] [Full Text] [Related]

  • 16. Mechanism of the induction of endoplasmic reticulum stress by the anti-cancer agent, di-2-pyridylketone 4,4-dimethyl-3-thiosemicarbazone (Dp44mT): Activation of PERK/eIF2α, IRE1α, ATF6 and calmodulin kinase.
    Merlot AM, Shafie NH, Yu Y, Richardson V, Jansson PJ, Sahni S, Lane DJR, Kovacevic Z, Kalinowski DS, Richardson DR.
    Biochem Pharmacol; 2016 Jun 01; 109():27-47. PubMed ID: 27059255
    [Abstract] [Full Text] [Related]

  • 17. Role of CAAT/enhancer binding protein homologous protein in panobinostat-mediated potentiation of bortezomib-induced lethal endoplasmic reticulum stress in mantle cell lymphoma cells.
    Rao R, Nalluri S, Fiskus W, Savoie A, Buckley KM, Ha K, Balusu R, Joshi A, Coothankandaswamy V, Tao J, Sotomayor E, Atadja P, Bhalla KN.
    Clin Cancer Res; 2010 Oct 01; 16(19):4742-54. PubMed ID: 20647473
    [Abstract] [Full Text] [Related]

  • 18. TRAP1 role in endoplasmic reticulum stress protection favors resistance to anthracyclins in breast carcinoma cells.
    Sisinni L, Maddalena F, Lettini G, Condelli V, Matassa DS, Esposito F, Landriscina M.
    Int J Oncol; 2014 Feb 01; 44(2):573-82. PubMed ID: 24297638
    [Abstract] [Full Text] [Related]

  • 19. Combined treatment with bortezomib plus bafilomycin A1 enhances the cytocidal effect and induces endoplasmic reticulum stress in U266 myeloma cells: crosstalk among proteasome, autophagy-lysosome and ER stress.
    Kawaguchi T, Miyazawa K, Moriya S, Ohtomo T, Che XF, Naito M, Itoh M, Tomoda A.
    Int J Oncol; 2011 Mar 01; 38(3):643-54. PubMed ID: 21174067
    [Abstract] [Full Text] [Related]

  • 20. Bortezomib suppresses function and survival of plasmacytoid dendritic cells by targeting intracellular trafficking of Toll-like receptors and endoplasmic reticulum homeostasis.
    Hirai M, Kadowaki N, Kitawaki T, Fujita H, Takaori-Kondo A, Fukui R, Miyake K, Maeda T, Kamihira S, Miyachi Y, Uchiyama T.
    Blood; 2011 Jan 13; 117(2):500-9. PubMed ID: 20956804
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.